Axcella Health Inc.

Rentabilité sur six mois: 0%
Rendement en dividendes: 0%
Secteur: Healthcare

0.4009 $

0 $ 0%
0.4009 $
4.58 $

paper.min_max_per_year

Calendrier des promotions Axcella Health Inc.

À propos de l'entreprise Axcella Health Inc.

Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Paramètres de base

IPO date
2019-05-09
ISIN
US05454B1052
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 0 0
P/BV 0 0
P/E 0 0
Efficacité
Nom Signification Grade
ROA 0 0
ROE 0 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA 0 10
Debt/Ratio 0 10
Debt/Equity 0 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 0 0
Rentabilité Ebitda, % 91.45 9
Rentabilité EPS, % -97.23 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.4009 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 0.4009 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 0.4009 $ 0.4009 $ 0.4009 $ 0 % 0 % 0 %
common.calendar.number_days.90d 0.4009 $ 0.4009 $ 0.4009 $ 0 % 0 % 0 %
common.calendar.number_days.180d 0.4009 $ 0.4009 $ 0.4009 $ 0 % 0 % 0 %
common.calendar.number_days.1y 0.4009 $ 0.4009 $ 4.58 $ 0 % 0 % 0 %
common.calendar.number_days.3y 2.45 $ 0.11 $ 375 $ -83.64 % 0 % 0 %
common.calendar.number_days.5y 4.49 $ 0.11 $ 375 $ -91.07 % 0 % 0 %
common.calendar.number_days.10y 0.11 $ 0.11 $ 375 $ 364.45 % 0 % 0 %
common.calendar.number_days.ytd 0.4009 $ 0.4009 $ 0.4009 $ 0 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Dr. Alison D. Schecter M.D. Pres of Strategy & Operations 525.53k 1964 (61 année)
Mr. David R. Epstein B.Sc., M.B.A. Consultant 228.34k 1962 (63 année)
Mr. Dan Kirby Sr. VP of Strategic Operations N/A
Mr. William R. Hinshaw Jr. Pres, CEO & Director 1969 (56 années)
Mr. Laurent Chardonnet Consultant 1965 (60 années)
Mr. Robert W. Crane Sr. VP & CFO 1959 (66 années)
Dr. Paul Fehlner J.D., Ph.D. Sr. VP, Chief Legal Officer & Corp. Sec. 1964 (61 année)
Ms. Virginia R. Dean Sr. VP & Chief People Officer 1966 (59 années)
Dr. Larry Bell Global Head of Regulatory Affairs & Pharmacovigilance and Sr. VP
Dr. Margaret James Koziel M.D. Sr. VP & Chief Medical Officer 1960 (65 années)

Informations sur l'entreprise

Adresse: United States, Cambridge. MA, 840 Memorial Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.axcellahealth.com